ClinicalTrials.Veeva

Menu

Multifunctional Nutrition Tube in Dysphagia for Nasopharyngeal Carcinoma

C

Copka Sonpashan

Status

Not yet enrolling

Conditions

Dysphagia

Treatments

Device: Nasogastric Tube Feeding
Device: Intermittent Oral-esophageal Tube Feeding
Behavioral: comprehensive rehabilitation therapy

Study type

Interventional

Funder types

Other

Identifiers

NCT06328868
IOE Nasopharyngeal Carcinoma

Details and patient eligibility

About

Baseline information (demographics, medical history, etc.), nutritional status at admission and after treatment, depression, dysphagia, and quality of life (QOL) after treatment as well as adverse events are compared.

Palliation to delayed dysphagia after radiotherapy for nasopharyngeal carcinoma (NPC) continues to be a challenge. Although nasogastric tube feeding (NGT) has been adopted widely, the weaknesses have yet to be improved by another enteral nutrition support mode. This study aims to observe the clinical efficacy of intermittent oro-esophageal tube feeding (IOE) in the treatment of delayed dysphagia after radiotherapy for (NPC). This is a prospective multicenter study with patients with delayed dysphagia after radiotherapy for NPC. Patients enrolled are randomly divided equally into the observation group and the control group. All patients receive conventional care, and the observation group received IOE while the control group received NGT for enteral nutrition support.

Full description

Palliation to delayed dysphagia after radiotherapy for nasopharyngeal carcinoma (NPC) continues to be a challenge. Although nasogastric tube feeding (NGT) has been adopted widely, the weaknesses have yet to be improved by another enteral nutrition support mode. This study aims to observe the clinical efficacy of intermittent oro-esophageal tube feeding (IOE) in the treatment of delayed dysphagia after radiotherapy for (NPC). This is a prospective multicenter study with patients with delayed dysphagia after radiotherapy for NPC. Patients enrolled are randomly divided equally into the observation group and the control group. All patients receive conventional care, and the observation group received IOE while the control group received NGT for enteral nutrition support. Baseline information (demographics, medical history, etc.), nutritional status at admission and after treatment, depression, dysphagia, and quality of life (QOL) after treatment as well as adverse events are compared.

Enrollment

80 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age between 18 and 65 years.
  • With the history of NPC and radiation therapy.
  • With dysphagia occurred at least three years after radiotherapy
  • Conscious and with stable vital signs;
  • Willing to participate and sign the written informed consent form either personally or by a family member.

Exclusion criteria

  • Presence of other diseases that might cause dysphagia.
  • With distant metastasis of tumors, or complicated with severe systemic disorders or malignancies.
  • Concurrent participation in other treatments that could interfere with the trial.
  • Inability to cooperate with treatment due to aphasia, mental health issues, etc.
  • Received tube feeding for enteral nutrition support within the past three years.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

80 participants in 2 patient groups

Intermittent Oral-esophageal Tube Feeding+comprehensive rehabilitation therapy
Experimental group
Description:
During the 15-day treatment, both groups of patients are hospitalized, while conventional care and enteral nutrition support are provided to the two groups. Specifically, conventional care includes health education, dietary adjustments, nasopharyngeal hygiene, management of risk factors (blood pressure and lipid control, etc.), exercise rehabilitation, and psychological support. The frequency and content of these interventions are arranged based on the patients; health condition. The observation group receives Intermittent Oro-esophageal Tube Feeding for enteral nutrition support
Treatment:
Behavioral: comprehensive rehabilitation therapy
Device: Intermittent Oral-esophageal Tube Feeding
Nasogastric Tube Feeding+comprehensive rehabilitation therapy
Active Comparator group
Description:
During the 15-day treatment, both groups of patients are hospitalized, while conventional care and enteral nutrition support are provided to the two groups. Specifically, conventional care includes health education, dietary adjustments, nasopharyngeal hygiene, management of risk factors (blood pressure and lipid control, etc.), exercise rehabilitation, and psychological support. The frequency and content of these interventions are arranged based on the patients; health condition.The control group receives nasogastric tube for enteral nutrition support
Treatment:
Behavioral: comprehensive rehabilitation therapy
Device: Nasogastric Tube Feeding

Trial contacts and locations

0

Loading...

Central trial contact

Lavie Ce

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems